Are you Dr. Ogino?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 25 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
# Brigham
Boston, MA 02115Phone+1 617-732-7510Fax+1 617-277-9015
Summary
- Dr. Shuji Ogino, MD is a board certified pathologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and Pennsylvania. He is affiliated with Brigham and Women's Hospital and is an Associate Professor of Pathology at Brigham and Women's Hospital.
Education & Training
University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1999 - 2000
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Pathology-Anatomic and Clinical, 1997 - 1999
Allegheny Health Network Medical Education Consortium (AGH)Residency, Pathology-Anatomic and Clinical, 1995 - 1997
Graduate School of Medicine and Faculty of Medicine, The University of TokyoClass of 1993
Certifications & Licensure
MA State Medical License 2001 - 2026
PA State Medical License 1996 - 2000- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Molecular Genetic Pathology
Publications & Presentations
PubMed
- 67 citationsPrognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer.Yoshifumi Baba, Katsuhiko Nosho, Kaori Shima, Jeffrey A. Meyerhardt, Andrew T. Chan
British Journal of Cancer. 2010-09-28 - 252 citationsPIK3CA Mutation Is Associated With Poor Prognosis Among Patients With Curatively Resected Colon CancerShuji Ogino, Katsuhiko Nosho, Gregory J. Kirkner, Kaori Shima, Natsumi Irahara
Journal of Clinical Oncology. 2009-03-20 - 13 citationsBody mass index and molecular subtypes of colorectal cancer.Neil Murphy, Christina C Newton, Mingyang Song, Nikos Papadimitriou, Michael Hoffmeister
Journal of the National Cancer Institute. 2023-02-08
Press Mentions
FDA Approves New Blood Test for Colon Cancer Screening: ‘Early Detection Is Critical’August 1st, 2024- Rise in Cancer Cases Among People Under 50 Alarming ExpertsMay 22nd, 2023
- Everything You Need to Know About Colorectal Cancer in CanadaApril 4th, 2023
- Join now to see all
